Zobrazeno 1 - 5
of 5
pro vyhledávání: '"K. A. Kaiser-Walters"'
Autor:
Sanjib Basu, P. Bonomi, O. Rouhi, Diana Escarzaga, Paolo Gattuso, D. Steker, K. A. Kaiser-Walters, Michael J. Liptay, John S. Coon, Jeffrey A. Borgia
Publikováno v:
Journal of Clinical Oncology. 28:7620-7620
7620 Background: Tumor metastasis is the primary cause of mortality in non-small cell lung cancer (NSCLC). Many pathways and biomarkers have been studied to clarify the mechanism of disease progres...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::877dfc519a4719c71c3576b72cc646b7
https://doi.org/10.1200/jco.2010.28.15_suppl.7620
https://doi.org/10.1200/jco.2010.28.15_suppl.7620
Autor:
K. A. Kaiser-Walters, P. Bonomi, Sanjib Basu, Mark Pool, F. Wong, W. Watkin, John S. Coon, Mary J. Fidler, A. Polish, Thomas A. Hensing
Publikováno v:
Journal of Clinical Oncology. 28:7552-7552
7552 Background: In pts with NSCLC, somatic activating mutations in the EGFR gene are associated with sensitivity to treatment with EGFR tyrosine kinase inhibitors (TKI). Loss of PTEN expression is...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::125131cabcb8bca9b7429c13a2f8222f
https://doi.org/10.1200/jco.2010.28.15_suppl.7552
https://doi.org/10.1200/jco.2010.28.15_suppl.7552
Autor:
Mary J. Fidler, D. Steker, Sanjib Basu, P. Bonomi, K. A. Kaiser-Walters, Marta Batus, John S. Coon, E. Hadziahmetovic
Publikováno v:
Journal of Clinical Oncology. 28:7034-7034
7034 Background: In a previous report, high pretreatment survivin was associated with poor prognosis and low pretreatment survivin was associated with pathological complete response (pCR) in stage ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf1959a9f23614b0ba9ea0c36b138eeb
https://doi.org/10.1200/jco.2010.28.15_suppl.7034
https://doi.org/10.1200/jco.2010.28.15_suppl.7034
Autor:
K. A. Kaiser-Walters, L. P. Faber, D. Steker, Anthony W. Kim, John S. Coon, P. Bonomi, A. Seba, E. C. Farlow, Sanjib Basu, Mary J. Fidler
Publikováno v:
Journal of Clinical Oncology. 27:7595-7595
7595 Background: Recently tumor molecular markers have shown promise as prognostic and predictive indicators for survival in early and advanced stage NSCLC patients (pts.) treated with chemotherapy. The objective of this study was to correlate immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::466e2cf6d1f1ac75ff1a7c166c59044a
https://doi.org/10.1200/jco.2009.27.15_suppl.7595
https://doi.org/10.1200/jco.2009.27.15_suppl.7595
Autor:
K. A. Kaiser-Walters, S. E. McCormack, John S. Coon, Mary J. Fidler, Sanjib Basu, Marta Batus, P. Bonomi, Lela Buckingham
Publikováno v:
Journal of Clinical Oncology. 26:22080-22080
22080 Background: The epidermal growth factor receptor (EGFR) signaling pathway has become an important target in lung cancer with the success of EGFR tyrosine kinase inhibitors (TKI). The IGFR-1 s...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b64666cf8628be8d25f1e39f620eb7e
https://doi.org/10.1200/jco.2008.26.15_suppl.22080
https://doi.org/10.1200/jco.2008.26.15_suppl.22080